Abstract
Na het lezen van dit hoofdstuk bent u in staat aan te geven wanneer u laboratoriumonderzoek moet doen bij de hartfalenpatiënt en wat u moet doen met afwijkende uitkomsten.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adwaruddin S, et al. Renal function, congestive heart failure, and amino terminal probrain natriuretic peptide measurement (PRIDE study). JACC 2006;47:91–7.
Braunwald. Biomarkers in heart failure. New Engl J Med 2008;358:2148–59.
Chen et al. Biomarkers in heart failure. Heart 2010;96:314–20.
Dennert et al. Acute virale myocarditis. Eur Heart J 2008;29:2073–82.
Emdin et al. Old and new biomarkers of heart failure. Eur J Heart Fail 2009;11:331–5.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2008;10:933–89.
Felker et al. Red Cell Distribution Width as a novel prognostic marker in heart failure. J Am Coll Cardiol 2007;50:40–7.
Hillege HL et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102(2):203–10.
Horwich et al. B Type natriuretic peptide levels in obese patients with advanced heart failure. JACC 2006;47:85–90.
Januzzi et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the international collaborative of NT-proBNP study. Eur Heart J 2006;27:330–7.
Jourain et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007;49(16):1733–9.
Kimmenade van et al. Usefulness of intermediate amino-terminal pro-Brain Natriuretic Peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol 2006;98:386–90.
Kimmenade van et al. Utility of aminoterminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 2006;48:1217–24.
Koglin et al. Role of Brain Natriuretic Peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934–41.
Lainchbury JG. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728–35.
Maisal et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004;44:1328–33.
Maisel et al. Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med 2002;347:161–7.
Moertl et al. Comparison of midregional proatrial and B type natriuretic peptides in chronic heart failure. JACC 2009;53:1783–90.
Mohammed et al. Natriuretic peptide guided heart failure management. Curr Clin Pharmacol 2009;4:87–94.
Peacock et al. Cardiac troponin and outcome in acute heart failure. New Engl J Med 2008;358:2117–26.
Pfisterer et al. BNP-guided vs. symptom-guided heart failure therapy. The trial of Intensified vs Standard Medical Therapy in Elderly patients with Congestive Heart Failure (TIME-CHF); randomized trial. JAMA 2009:301(4):383–92.
Prakash et al. The key to unraveling the mystery of mortality in heart failure. An integrated approach. Circulation 2003;107:1719–21.
Shah et al. STARBITE: a randomized pilot trial of BNP-guided therapy in patients with advanced heart failure. Circulation 2006;114(II):528.
Von Hoeling et al. Mid Regional Pro-Adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 2010 Mar.
Yandle T, Troughton R. Improving risk stratification in heart failure: A role for new biomarkers? Editorial. Eur J Heart Fail 2010;12:315–8.
Zitterman et al. Vitamin D insufficiency in congestive heart failure: Why and what to do about it? Heart Fail Rev 2006;11:25–33.
Zittermann et al. Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105–12.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Bohn Stafleu van Loghum, onderdeel van Springer Media
About this chapter
Cite this chapter
de Jong, S.F.A.S. (2011). Hartfalen: laboratoriumonderzoek. In: Meursing, B.T.J., Lamfers, E.J.P. (eds) Handboek hartfalen. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-8543-0_5
Download citation
DOI: https://doi.org/10.1007/978-90-313-8543-0_5
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-8542-3
Online ISBN: 978-90-313-8543-0
eBook Packages: Dutch language eBook collection